PRKN and hepatocellular carcinoma: While we proposed parkin as a profibrotic molecule for liver fibrosis, it was revealed that parkin deficiency induced hepatocyte proliferation and resistance to apoptosis, resulting in the development of hepatocellular carcinoma [49,50].